WEG
SMMT icon

World Equity Group’s Summit Therapeutics SMMT Stock Holding History

World Equity Group’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,854
Closed -$390K – 378
2025
Q3 		$390K Buy
18,854
+4,287
+29% +$104K 0.09% 221
2025
Q2 		$310K Sell
14,567
-205
-1% -$4.67K 0.08% 238
2025
Q1 		$285K Sell
14,772
-14,062
-49% -$282K 0.08% 233
2024
Q4 		$515K Buy
28,834
+13,992
+94% +$271K 0.11% 188
2024
Q3 		$325K Buy
14,842
+2,063
+16% +$28.9K 0.12% 171
2024
Q2 		$99.7K Buy
12,779
+153
+1% +$826 0.03% 265
2024
Q1 		$52.3K Buy
+12,626
New +$50.2K 0.01% 306

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PCMH
Polymer Capital Management (HK) Hong Kong $1.98B AUM 210.13% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

World Equity Group's SMMT Position: Q4 2025 in Review

World Equity Group sold out of Summit Therapeutics (SMMT) in Q4 2025, closing a stake of 18,854 shares — an estimated $390K sold.

World Equity Group first reported a position in SMMT in Q1 2024 and held it in 7 quarters. The position peaked at $515K in Q4 2024. 206 funds tracked by Wall St. Rank hold SMMT as of Q4 2025.

  • World Equity Group reported no remaining Summit Therapeutics position as of Q4 2025 after selling out during the quarter.
  • World Equity Group sold 18,854 Summit Therapeutics shares in Q4 2025, an estimated $390K.
  • World Equity Group first reported a position in Summit Therapeutics in Q1 2024 and held it in 7 quarters.
  • World Equity Group's Summit Therapeutics position peaked at $515K in Q4 2024.
  • 206 funds tracked by Wall St. Rank held Summit Therapeutics as of Q4 2025.

Based on World Equity Group's 13F filing for Q4 2025, filed 12 Jan 2026.